Physician

Donald Charles Vile, M.D.

According to 2025 Medicare claims, Donald Vile, M.D. (NPI: 1366862484) practices hematology/oncology in the Roanoke, VA market, with the plurality of this provider's patient population coming from Roanoke City, VA. This provider's primary affiliated billing organization is ONCOLOGY AND HEMATOLOGY ASSOCIATES OF SOUTHWEST VIRGINIA, INC. (NPI: 1487621496; TIN: 541922084) and primary practice location at 24014-2419. Vile is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033), participating under the MSSP model.

Vile's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 639 traditional Medicare patients, billed 110,757 HCPCS/CPT codes, and received $2,388,628 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,262 prescription claims across 182 beneficiaries totaling $3,049,081 in drug costs, led by Calquence (Acalabrutinib Maleate). DME data shows 71 claims. Open Payments data shows 75 records totaling $598,936. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $3,083 to $2,388,628. Similarly, Part D prescription costs have risen steadily, from $2,686 to $3,049,081. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.3M$2.7M2019 Medicare payment: $3,083 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $677,818 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,093,233 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,535,290 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,694,007 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,388,628 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20192628$3,083
202032240,941$677,818
2021706158,779$2,093,233
2022762148,887$2,535,290
2023739147,083$2,694,007
2024639110,757$2,388,628

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.5M$3.0M2016 Drug cost: $2,686 (USD; Tot_Drug_Cst)2017 Drug cost: $17,766 (USD; Tot_Drug_Cst)2020 Drug cost: $7,002 (USD; Tot_Drug_Cst)2021 Drug cost: $850,236 (USD; Tot_Drug_Cst)2022 Drug cost: $2,567,486 (USD; Tot_Drug_Cst)2023 Drug cost: $2,600,146 (USD; Tot_Drug_Cst)2024 Drug cost: $3,049,081 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/R54$2,686
20171354$17,766
2018N/RN/RN/R
2019N/RN/RN/R
20203588$7,002
2021109613$850,236
20221501,089$2,567,486
20231761,276$2,600,146
20241821,262$3,049,081

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$8.7K$17K2021 Medicare payment: $7,395 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $1,536 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $17,386 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $2,766 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202112113$7,395
2022N/R46$1,536
202345133$17,386
20241371$2,766

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more139240$90
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more157213$58
80053Blood test, comprehensive group of blood chemicals219973$10
36415Insertion of needle into vein for collection of blood sample241767$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count2841,228$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CalquenceAcalabrutinib Maleate25750$390,491
LenalidomideLenalidomide23644$339,407
BrukinsaZanubrutinib21630$296,083
PomalystPomalidomide12336$269,760
VenclextaVenetoclax16457$229,092

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R11$1,341
J8521Capecitabine, oral, 500 mgNN/R16$653
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodN1322$376
E0431Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubingYN/R11$246
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R11$150

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.12$204Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.63$598,732Janssen Research & Development, LLC
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Donald Charles Vile, M.D.?

Tedicare shows public-source Medicare data for Donald Charles Vile, M.D. (NPI 1366862484), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Donald Charles Vile, M.D. have ACO affiliation data?

Donald Charles Vile, M.D. is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033).

What billing organization is linked to Donald Charles Vile, M.D.?

Donald Charles Vile, M.D. is linked to ONCOLOGY AND HEMATOLOGY ASSOCIATES OF SOUTHWEST VIRGINIA, INC. (billing NPI 1487621496) in the available physician profile data.

Does Donald Charles Vile, M.D. have Open Payments data?

Donald Charles Vile, M.D. has 75 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.